Testing effectiveness (Phase 2)Ended earlyNCT02309515
What this trial is testing
Lenalidomide in Improving Immune Response to Vaccine Therapy in Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Monoclonal B Cell Lymphocytosis
Who this might be right for
Monoclonal B-Cell LymphocytosisStage 0 Chronic Lymphocytic LeukemiaStage I Chronic Lymphocytic Leukemia+1 more
Mayo Clinic 12